Neoprobe Corporation (NYSE Amex: NEOP) today announced that Dr. Mark Pykett, Neoprobe’s President and Chief Executive Officer will be participating in the following investor conferences over the coming weeks:
- Deutsche Bank's 5th Annual Med Tools Investor Forum, December 7-8, 2011 in Boston, Massachusetts. Management is scheduled to meet with institutional investors.
- Oppenheimer & Co.’s 22nd Annual Healthcare Conference, December 13-14, 2011 in New York City. Management is invited to present an overview of the Company.
- 2012 Biotech Showcase, January 9-11, 2012 in San Francisco. Management is invited to present an overview of the Company.